| Literature DB >> 23358883 |
Philippe Kastner1, Arnaud Dupuis, Marie-Pierre Gaub, Raoul Herbrecht, Patrick Lutz, Susan Chan.
Abstract
The Ikaros transcription factor is crucial for many aspects of hematopoiesis. Loss of function mutations in IKZF1, the gene encoding Ikaros, have been implicated in adult and pediatric B cell acute lymphoblastic leukemia (B-ALL). These mutations result in haploinsufficiency of the Ikaros gene in approximately half of the cases. The remaining cases contain more severe or compound mutations that lead to the generation of dominant-negative proteins or complete loss of function. All IKZF1 mutations are associated with a poor prognosis. Here we review the current genetic, clinical and mechanistic evidence for the role of Ikaros as a tumor suppressor in B-ALL.Entities:
Keywords: B cell leukemia; Ikaros; tumor suppressor
Year: 2013 PMID: 23358883 PMCID: PMC3555193
Source DB: PubMed Journal: Am J Blood Res ISSN: 2160-1992